501 filings
15-12G
ENDV
Endonovo Therapeutics, Inc.
2 Feb 24
Securities registration termination
5:23pm
8-K
ENDV
Endonovo Therapeutics, Inc.
3 Jan 24
Entry into a Material Definitive Agreement
5:30pm
10-Q
2023 Q3
ENDV
Endonovo Therapeutics, Inc.
Quarterly report
28 Dec 23
8:50pm
8-K
ENDV
Endonovo Therapeutics, Inc.
4 Dec 23
Entry into a Material Definitive Agreement
9:08am
NT 10-Q
ENDV
Endonovo Therapeutics, Inc.
15 Nov 23
Notice of late quarterly filing
12:21pm
8-K
ENDV
Endonovo Therapeutics, Inc.
12 Oct 23
Other Events
6:03am
1-A/A
ENDV
Endonovo Therapeutics, Inc.
25 Aug 23
Offering $5.00 mm in Equity
7:04am
10-Q
2023 Q2
ENDV
Endonovo Therapeutics, Inc.
Quarterly report
21 Aug 23
5:16pm
NT 10-Q
ENDV
Endonovo Therapeutics, Inc.
14 Aug 23
Notice of late quarterly filing
5:55pm
1-A/A
ENDV
Endonovo Therapeutics, Inc.
14 Jun 23
Offering $5.00 mm in Equity
2:27pm
10-Q
2023 Q1
ENDV
Endonovo Therapeutics, Inc.
Quarterly report
22 May 23
4:09pm
NT 10-Q
ENDV
Endonovo Therapeutics, Inc.
15 May 23
Notice of late quarterly filing
6:32pm
10-K
2022 FY
ENDV
Endonovo Therapeutics, Inc.
Annual report
17 Apr 23
4:35pm
NT 10-K
ENDV
Endonovo Therapeutics, Inc.
31 Mar 23
Notice of late annual filing
3:54pm
8-K
ENDV
Endonovo Therapeutics, Inc.
29 Mar 23
Entry into a Material Definitive Agreement
7:00am
10-Q
2022 Q3
ENDV
Endonovo Therapeutics, Inc.
Quarterly report
21 Nov 22
4:31pm
NT 10-Q
ENDV
Endonovo Therapeutics, Inc.
14 Nov 22
Notice of late quarterly filing
9:26am
8-K
ENDV
Endonovo Therapeutics, Inc.
27 Sep 22
Entry into a Material Definitive Agreement
1:30pm
10-Q
2022 Q2
ENDV
Endonovo Therapeutics, Inc.
Quarterly report
22 Aug 22
9:12am